Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.

Kennedy has in particular focused on Gardasil, the HPV vaccine. A lawyer by trade, he has helped facilitate hundreds of potential lawsuits aimed at pharmaceutical company Merck, which manufactures ...

Merck’s recent earnings call revealed that although the company generated worldwide sales of $64.2 billion—a 7% increase over 2023—the company will be temporarily suspending Gardasil shipments to ...

Merck reported a 2% decline in Gardasil sales, after reaching a peak of $8.9 billion in 2023. Now with shipments to China paused, the HPV vaccine faces significant headwinds going into 2025.

The drugmaker plans to temporarily pause shipments of its Gardasil vaccine to China through at least the middle of the year. Merck gave no explanation in its fourth-quarter earnings report for the ...

The drugmaker plans to temporarily pause shipments of its Gardasil vaccine to China at least through the middle of the year. Chairman and CEO Robert Davis told analysts the pause will help pare ...

The company said that sales range reflects a decision to halt shipments of Gardasil, a vaccine that prevents cancer from HPV, into China beginning in February and going through at least mid-2025.